Gensight will attend the American Academy of Neurology (AAN) Annual Meeting to be held virtually from April 17 to 22.

A scientific abstract has been accepted for a scientific poster session.

Abstract Title:  Evaluation of rAAV2/2-ND4 Gene Therapy Efficacy in Leber Hereditary Optic Neuropathy Using an External Control Group of Untreated Patients

  • Presenter: Nancy J. Newman, MD, LeoDelle Jolley Professor of Ophthalmology and Neurology, Emory University School of Medicine, Atlanta, GA. Principal Investigator in the RESCUE trial.
  • Session Name: P21: Neuro-ophthalmology and the Afferent Visual System
  • Topic: Neuro-ophthalmology/Neuro-otology
  • Program Number: 011

Read more:  https://bit.ly/3t0trUI

This abstract, “Evaluation of rAAV2/2-ND4 Gene Therapy Efficacy in Leber Hereditary Optic Neuropathy Using an External Control Group of Untreated Patients”, has been selected for the merit of distinction in 2021. Each year the American Academy of Neurology and the Science Committee review the highest rated abstracts in each topic. Distinction is awarded to the abstract deemed to be the top in its topic category in quality of study and interest to the neurologic community.

Abstracts of distinction are highlighted in the Annual Meeting Science publication. They will also be recognized during the meeting in the online platform.